Table 1 Participants Social Demographic and Clinical characteristics according to Electrolyte exposure
Characteristics | Study arms | P-value | |
|---|---|---|---|
NaCl + Electrolyte n (%) | NaCl alone n (%) | ||
Sex | |||
Male | 4 (8.2) | 2 (4.0) | 0.392 |
Female | 45 (91.8) | 48 (96.0) | |
Age (years) | |||
30–45 | 18 (36.7) | 7 (14.0) | 0.114 |
46–64 | 21 (42.9) | 35 (70) | |
>65 | 10 (20.4) | 8 (16.0) | |
BMI (kg/m2) | |||
<18.5 | 6 (12.2) | 5 (10.0) | 0.942 |
18.5–24.9 | 23 (46.9) | 22 (44.0) | |
25–29.9 | 13 (26.5) | 14 (28.0) | |
≥ 30 | 7 (14.3) | 9 (18.0) | |
Smoking status | |||
Yes | 2 (4.1) | 1 (2.0) | 0.552 |
No | 47 (95.9) | 49 (98.0) | |
Alcohol use | |||
Yes | 4 (8.2) | 5 (10.0) | 0.753 |
No | 45 (91.8) | 45 (90.0) | |
Traditional medicine use | |||
Yes | 4 (8.2) | 1 (2.0) | 0.168 |
No | 45 (91.8) | 49 (98.0) | |
Co-morbidity | |||
Yes | 6 (12.2) | 6 (12.0) | 0.640 |
No | 43 (87.8) | 44 (98.0) | |
Type of cancer | |||
Cervical | 43 (87.8) | 45 (90.0) | 0.590 |
Esophageal | 4 (8.2) | 1 (2.0) | |
Oral | 1 (2.0) | 2 (4.0) | |
Others | 1 (2.0) | 2 (4.0) | |
Chemotherapy regimen use | |||
Cisplatin alone | 47 (95.9) | 46 (92.0) | 0.418 |
Cisplatin contained regimen | 2 (4.1) | 4 (8.0) | |
Cisplatin dose (mg) | |||
50–60 | 25 (51) | 25 (50) | 0.441 |
61–70 | 20 (40.8) | 15 (30) | |
71–80 | 2 (4.1) | 7 (14) | |
81–90 | 0 | 0 | |
>90 | 2 (4.1) | 3 (6) | |